161 related articles for article (PubMed ID: 37671260)
1. Hemodynamic testing to guide vasodilator therapy in cardiac amyloidosis.
Rucker DM; Siddiqi OK; Pimentel DR; Luptak I
J Cardiol Cases; 2023 Sep; 28(3):105-108. PubMed ID: 37671260
[TBL] [Abstract][Full Text] [Related]
2. [Hemodynamic guidelines in the treatment of acute myocardial infarction by means of vasodilators].
Zilcher H
Acta Med Austriaca Suppl; 1979; 15():1-34. PubMed ID: 161946
[TBL] [Abstract][Full Text] [Related]
3. Light-Chain (AL) Cardiac Amyloidosis Presenting as Heart Failure With Reduced Ejection Fraction.
Santiago LE; Alvi AT; Melnychuk V; Mesquita P; Aneja P
Cureus; 2024 Feb; 16(2):e55271. PubMed ID: 38558722
[TBL] [Abstract][Full Text] [Related]
4. Hemodynamic responsiveness to short- and long-acting vasodilators in left ventricular failure.
Franciosa JA; Cohn JN
Am J Med; 1978 Jul; 65(1):126-33. PubMed ID: 685986
[TBL] [Abstract][Full Text] [Related]
5. Hemodynamic comparison of dopexamine and nitroprusside at high and low doses in patients with coronary artery disease and impaired left ventricular function.
Ikram H; Foy SG; Low CJ; Redfern SA; Shirlaw TM; Bennett SI; Crozier IG
J Cardiovasc Pharmacol; 1995 Nov; 26(5):777-83. PubMed ID: 8637193
[TBL] [Abstract][Full Text] [Related]
6. Effects of vasodilation in heart failure with preserved or reduced ejection fraction implications of distinct pathophysiologies on response to therapy.
Schwartzenberg S; Redfield MM; From AM; Sorajja P; Nishimura RA; Borlaug BA
J Am Coll Cardiol; 2012 Jan; 59(5):442-51. PubMed ID: 22281246
[TBL] [Abstract][Full Text] [Related]
7. Refractory acute decompensated heart failure: an observational study on a noninvasive hemodynamic monitoring system aimed at improving the therapeutic approach.
Frea S; Franco E; Najd K; Panella S; Pinneri F
J Cardiovasc Med (Hagerstown); 2010 Sep; 11(9):655-61. PubMed ID: 20308915
[TBL] [Abstract][Full Text] [Related]
8. Amyloid Cardiomyopathy in the Emergency Department.
Baca M; Newberry M
J Emerg Med; 2019 Feb; 56(2):205-209. PubMed ID: 30553561
[TBL] [Abstract][Full Text] [Related]
9. Noninvasive Diagnostic Modalities in an Isolated Case of Cardiac Amyloidosis.
Lewars J; Wazir H; Gordon B; Faluyi U; Girgis Y
Cureus; 2021 Apr; 13(4):e14608. PubMed ID: 34040908
[TBL] [Abstract][Full Text] [Related]
10. Nitroprusside in critically ill patients with left ventricular dysfunction and aortic stenosis.
Khot UN; Novaro GM; Popović ZB; Mills RM; Thomas JD; Tuzcu EM; Hammer D; Nissen SE; Francis GS
N Engl J Med; 2003 May; 348(18):1756-63. PubMed ID: 12724481
[TBL] [Abstract][Full Text] [Related]
11. Acute reduction of atrial overload during vasodilator and diuretic therapy in advanced congestive heart failure.
Hamilton MA; Stevenson LW; Child JS; Moriguchi JD; Woo M
Am J Cardiol; 1990 May; 65(18):1209-12. PubMed ID: 2186605
[TBL] [Abstract][Full Text] [Related]
12. Hemodynamic assessment in heart failure.
Jain CC; Borlaug BA
Catheter Cardiovasc Interv; 2020 Feb; 95(3):420-428. PubMed ID: 31507065
[TBL] [Abstract][Full Text] [Related]
13. Relative contribution of inotropic and vasodilator effects to amrinone-induced hemodynamic improvement in congestive heart failure.
Konstam MA; Cohen SR; Weiland DS; Martin TT; Das D; Isner JM; Salem DN
Am J Cardiol; 1986 Feb; 57(4):242-8. PubMed ID: 3004184
[TBL] [Abstract][Full Text] [Related]
14. Afterload reduction and cardiac performance. Physiologic basis of systemic vasodilators as a new approach in treatment of congestive heart failure.
Mason DT
Am J Med; 1978 Jul; 65(1):106-25. PubMed ID: 99030
[TBL] [Abstract][Full Text] [Related]
15. Acute Decompensated Heart Failure Due to Combined Ischemic Cardiomyopathy and Cardiac Amyloidosis.
Bosah AN; Tobaa A; Gajjar K; Kashyap K; Alpert C
Cureus; 2022 Dec; 14(12):e32281. PubMed ID: 36628045
[TBL] [Abstract][Full Text] [Related]
16. Senile Systemic Amyloidosis: An Underdiagnosed Disease.
Manso MC; Marques DP; Rocha SL; Rodeia SC; Domingos R
Eur J Case Rep Intern Med; 2017; 4(9):000725. PubMed ID: 30755970
[TBL] [Abstract][Full Text] [Related]
17. Hemodynamic effects of vasodilators and long-term response in heart failure.
Franciosa JA; Dunkman WB; Leddy CL
J Am Coll Cardiol; 1984 Jun; 3(6):1521-30. PubMed ID: 6325522
[TBL] [Abstract][Full Text] [Related]
18. Implications of the hemodynamic optimization approach guided by right heart catheterization in patients with severe heart failure.
Rohde LE; Furian T; Campos C; Biolo A; Rabelo E; Foppa M; Clausell N
Arq Bras Cardiol; 2002 Mar; 78(3):261-6. PubMed ID: 11967581
[TBL] [Abstract][Full Text] [Related]
19. Ambulatory long-term vasodilator therapy for chronic refractory heart failure: hemodynamic evaluation and clinical response.
Saito S; Ichikawa M; Ozawa Y; Yumikura S; Nagasawa M; Hibiya K; Tamura Y; Tomobe K; Hatano M
Jpn Circ J; 1984 Apr; 48(4):350-6. PubMed ID: 6425526
[TBL] [Abstract][Full Text] [Related]
20. [The natural history of dilated cardiomyopathy and pathophysiology of congestive heart failure].
Hirota Y; Saito T; Kita Y; Shimizu G; Kino M; Kawamura K
J Cardiogr Suppl; 1986; (9):67-76. PubMed ID: 3760619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
